We bring you the latest news from the healthcare about the health care in the United Kingdom.

maandag 17 september 2018

Modern Pathology - Table of Contents alert Volume 31 Issue 9

If you are unable to see the message below, click here to view.
Modern Pathology

Advertisement
 

Advanced Imaging with Proven Optics


Olympus is dedicated to your work, vision, and science. Through innovation and service, we seek to aide in your discoveries, advance your research, and inspire you to explore new possibilities. Our wide range of microscopes are built with the optical excellence and proven application expertise you can depend on. Your Science Matters™.

> Learn more about Olympus microscopes
 
TABLE OF CONTENTS

Volume 31, Issue 9

In this issue
Inside the USCAP Journals
Article
Also new
AOP
 

Inside the USCAP Journals

Inside the USCAP Journals

 

Modern Pathology 2018 31 :1344 - 1345; September 14, 2018; 10.1038/s41379-018-0133-4

 

Abstract | Full Text

Article

RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations

Xiao-tong Wang, Qiu-yuan Xia, Sheng-bing Ye, Xuan Wang, Rui Li et al.

Modern Pathology 2018 31 :1346 - 1360; April 30, 2018; 10.1038/s41379-018-0051-5

 

Abstract | Full Text

Endothelial trans-differentiation in glioblastoma recurring after radiotherapy

Ivana De Pascalis, Liliana Morgante, Simone Pacioni, Quintino Giorgio D’Alessandris, Stefano Giannetti et al.

Modern Pathology 2018 31 :1361 - 1366; April 30, 2018; 10.1038/s41379-018-0046-2

 

Abstract | Full Text

Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases

Nadjla Alsadoun, Gaëtan MacGrogan, Caroline Truntzer, Magali Lacroix-Triki, Isabelle Bedgedjian et al.

Modern Pathology 2018 31 :1367 - 1380; May 21, 2018; 10.1038/s41379-018-0047-1

 

Abstract | Full Text

Assessment of programmed cell death ligand-1 expression by 4 diagnostic assays and its clinicopathological correlation in a large cohort of surgical resected non-small cell lung carcinoma

Anthony W. H. Chan, Joanna H. M. Tong, Johnny S. H. Kwan, Chit Chow, Lau Y. Chung et al.

Modern Pathology 2018 31 :1381 - 1390; April 30, 2018; 10.1038/s41379-018-0053-3

 

Abstract | Full Text

Intraoperatively measured tumor size and frozen section results should be considered jointly to predict the final pathology for lung adenocarcinoma

Erjia Zhu, Huikang Xie, Chenyang Dai, Liping Zhang, Yan Huang et al.

Modern Pathology 2018 31 :1391 - 1399; May 11, 2018; 10.1038/s41379-018-0056-0

 

Abstract | Full Text

Glypican-1 immunohistochemistry does not separate mesothelioma from pulmonary adenocarcinoma

Kenrry Chiu, Lawrence Lee, Simon Cheung & Andrew M. Churg

Modern Pathology 2018 31 :1400 - 1403; May 21, 2018; 10.1038/s41379-018-0066-y

 

Abstract | Full Text

Pulmonary adenocarcinoma with high-grade fetal adenocarcinoma component has a poor prognosis, comparable to that of micropapillary adenocarcinoma

Masaki Suzuki, Yukio Nakatani, Hiroyuki Ito, Hiroto Narimatsu, Kozo Yamada et al.

Modern Pathology 2018 31 :1404 - 1417; May 21, 2018; 10.1038/s41379-018-0057-z

 

Abstract | Full Text

Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement

Jiyeon Hyeon, Boram Lee, So-Hyun Shin, Hae Yong Yoo, Seok Jin Kim et al.

Modern Pathology 2018 31 :1418 - 1428; May 15, 2018; 10.1038/s41379-018-0064-0

 

Abstract | Full Text

Polyoma virus-associated carcinomas of the urologic tract: a clinicopathologic and molecular study

Deepika Sirohi, Charlie Vaske, Zack Sanborn, Steven C. Smith, Michelle D. Don et al.

Modern Pathology 2018 31 :1429 - 1441; May 15, 2018; 10.1038/s41379-018-0065-z

 

Abstract | Full Text

SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma

David L. Kolin, Fei Dong, Michele Baltay, Neal Lindeman, Laura MacConaill et al.

Modern Pathology 2018 31 :1442 - 1456; April 26, 2018; 10.1038/s41379-018-0049-z

 

Abstract | Full Text

Other immunomodulatory agent-related lymphoproliferative diseases: a single-center series of 72 biopsy-confirmed cases

Lukas Marcelis, Charlien Berghen, Alexandra De Zutter, Pauline Biesemans, Peter Vandenberghe et al.

Modern Pathology 2018 31 :1457 - 1469; May 15, 2018; 10.1038/s41379-018-0054-2

 

Abstract | Full Text

MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas

Wenting Huang, L. Jeffrey Medeiros, Pei Lin, Wei Wang, Guilin Tang et al.

Modern Pathology 2018 31 :1470 - 1478; May 21, 2018; 10.1038/s41379-018-0067-x

 

Abstract | Full Text

Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin

Ansuman T. Satpathy, Ryanne A. Brown, Ellen Gomulia, Carlos G. Briseño, Maxwell R. Mumbach et al.

Modern Pathology 2018 31 :1479 - 1486; May 09, 2018; 10.1038/s41379-018-0052-4

 

Abstract | Full Text

Advertisement
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Modern Pathology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature